[시장보고서]세계의 수면 보조제 시장 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2033년)

세계의 수면 보조제 시장 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2033년)

Sleep Aids Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

상품코드 : 1500817

리서치사 : Persistence Market Research

발행일 : 2024년 06월

페이지 정보 : 영문 164 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 6,889,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,061,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 11,716,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

Persistence Market Research는 전 세계 수면 보조제 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회, 과제 등 중요한 시장 역학을 철저히 평가하고 시장 구조에 대한 자세한 통찰력을 제공합니다. 이 설문조사 보고서는 2024년부터 2033년까지 세계 수면 보조제 시장 예측 성장 궤도를 개설하는 독점 데이터와 통계를 게재합니다.

주요 인사이트

수면 보조제 시장 규모(2024E) : 296억 달러
예측 시장 가치(2033F) : 432억 달러
세계 시장 성장률(CAGR 2024-2033년) : 4.3% : 4.3%

수면 보조제 시장 : 조사 범위

수면 보조제는 불면증, 수면 무호흡 증후군, 하지불안 증후군, 수면의 질에 영향을 미치는 기타 증상 등 다양한 수면장애 관리에 중요한 역할을 합니다. 수면 보조제에는 수면 패턴의 개선, 수면 시간의 연장, 수면 전반의 건강 촉진을 목적으로 한 다양한 제품 및 치료법이 포함됩니다. 수면 보조제 시장은 의약품, 의료기기, 행동 요법을 통해 다양한 층에 대응하고, 만성 수면 문제와 임시 수면 문제 모두에 대응하고 있습니다.

시장 성장 촉진요인:

세계 수면 보조제 시장은 라이프 스타일 변화, 스트레스, 노화로 인한 수면장애의 유병률 증가 등 몇 가지 중요한 요인에 의해 견인되고 있습니다. 수면 위생의 중요성과 건강 전반에 미치는 영향에 대한 의식이 높아짐에 따라 효과적인 수면 보조제에 대한 수요가 증가하고 있습니다. 수면 추적 장치, 웨어러블 기술, 개인화 수면 요법과 같은 기술의 진보로 치료 성과와 환자의 어드레싱이 향상되었습니다. 또한 원격 의료 및 디지털 건강 플랫폼의 수용 확대로 수면 평가 및 치료에 대한 원격 액세스가 용이해지고 시장 범위가 확대되고 있습니다.

시장 성장 억제요인:

유망한 성장이 예상되는 것, 수면 보조제 시장은 규제 당국의 승인, 특정 약물의 장기 사용과 관련된 안전성 우려, 비 약리학 적 개입의 효과 변동 등과 관련된 문제에 직면합니다. 수면 보조제의 승인 및 판매에 대한 엄격한 규제는 제조업체 및 건강 관리 제공업체에게 규정 준수 부담을 부과하여 시장 진출 전략 및 운영 비용에 영향을 미칩니다. 또한 지역에 따라서는 수면장애치료에 대한 상환범위가 한정되어 있는 것도 특히 신흥경제권에서는 시장 침투 장벽이 되고 있습니다.

시장 기회:

수면 보조제 시장은 수면 진단 및 치료 방법의 기술 혁신으로 큰 성장 기회를 제공합니다. 신경 자극 장치, 인지 행동 치료 및 신규 약리학 약물의 진보로 임상 의사와 환자가 사용할 수있는 치료 옵션이 확대되고 있습니다. 또한, 수면 연구에서 인공지능(AI)과 빅데이터 분석의 통합은 맞춤 치료 계획과 수면장애의 예측적 통찰력을 촉진합니다. 새로운 기회를 활용하고 진화하는 규제 상황을 극복하기 위해서는 건강 관리 제공업체, 기술 개발자 및 규제 기관의 전략적 협력이 필수적입니다.

이 보고서에서 다루는 주요 질문

세계 수면 보조제 시장의 성장을 가속하는 주요 요인은 무엇인가?
어떤 유형의 수면 보조제와 치료 접근법이 다양한 층에서지지를 모으고 있는가?
기술의 진보는 수면 보조제 시장 경쟁 구도를 어떻게 바꾸고 있는가?
수면 보조제 시장에 기여하는 주요 기업은 누군가가 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
세계의 수면 보조제 시장의 새로운 동향과 미래 전망은?

소개/ 주요 조사 결과
2019-2023년 제품별 시장 규모의 과거 분석
현재 및 미래 시장 규모의 분석과 예측, 제품별(2024-2033년)
- 약물
  - 불면증 치료제
    - 독세핀 염산염
    - 에스조피크론
    - 라멜테온
    - 트리아졸람
    - 자레프론
    - 쿠아제팜
    - 기타
  - 기면증 치료제
    - 모다피닐
    - 옥시베이트 나트륨
    - 아모다피닐
    - 기타
- 장치
  - CPAP 장치
  - BiPAP 장치
  - APAP 장치
- 기타
  - 매트리스와 베개
  - 턱끈
  - 마우스피스와 코용 기구
제품별 시장의 매력 분석

제9장 세계의 수면 보조제 시장 분석(적응증별)

소개/ 주요 조사 결과
과거 시장 규모 분석, 적응증별(2019-2023년)
현재 및 미래 시장 규모의 분석과 예측, 적응증별(2024-2033년)
- 불면증
- 수면 부족
- 기면증
- 수면시 무호흡
- 기타
적응증별 시장의 매력 분석

제10장 세계의 수면 보조제 시장 분석(유통 채널별)

소개/ 주요 조사 결과
과거 시장 규모 분석, 유통 채널별(2019-2023년)
현재 및 미래 시장 규모의 분석과 예측, 유통 채널별(2024-2033년)
- 병원 약국
- 소매 약국
- 전자상거래
- 약국
- 기타
유통 채널별 시장의 매력 분석

제11장 지역별 세계의 수면 보조제 시장 분석

소개
지역별 시장 규모의 과거 분석(2019-2023년)
현재 및 미래 시장 매출의 분석과 예측(2024-2033년)
- 북미
- 라틴아메리카
- 유럽
- 동아시아
- 남아시아
- 오세아니아
- 중동 및 아프리카(중동 및 아프리카)
지역별 시장의 매력 분석

제12장 북미 수면 보조제 시장 분석

제13장 라틴아메리카 수면 보조제 시장 분석

제14장 유럽 수면 보조제 시장 분석

제15장 동아시아 수면 보조제 시장 분석

제16장 남아시아 수면 보조제 시장 분석

제17장 오세아니아의 수면 보조제 시장

제18장 중동 및 아프리카(중동 및 아프리카) 수면 보조제 시장 분석

제19장 시장 구조 분석

기업 Tier별 시장 분석
주요 기업의 시장 점유율 분석
시장현재분석

제20장 경쟁 분석

경쟁 대시보드
경쟁 벤치마킹
경쟁의 상세
- ResMed Inc.
- Koninklijke Philips NV
- Merck &Co. Inc.
- Drive DeVilbiss Healthcare LLC
- GlaxoSmithKline Plc.
- Fisher &Paykel Healthcare Limited
- Sanofi SA
- Pfizer Inc

제21장 사용된 전제조건과 약어

제22장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide Sleep Aids Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Sleep Aids Market from 2024 to 2033.

Key Insights:

Sleep Aids Market Size (2024E): USD 29.6 Billion
Projected Market Value (2033F): USD 43.2 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 4.3%

Sleep Aids Market - Report Scope:

Sleep aids play a crucial role in managing various sleep disorders, including insomnia, sleep apnea, restless legs syndrome, and other conditions affecting sleep quality. These aids encompass a spectrum of products and therapies designed to improve sleep patterns, enhance sleep duration, and promote overall sleep health. The sleep aids market caters to diverse demographics through pharmaceuticals, medical devices, and behavioral therapies, addressing both chronic and occasional sleep issues.

Market Growth Drivers:

The global sleep aids market is driven by several key factors, including increasing prevalence of sleep disorders due to lifestyle changes, stress, and aging population. Rising awareness about the importance of sleep hygiene and its impact on overall health is amplifying demand for effective sleep aids. Technological advancements in sleep tracking devices, wearable technologies, and personalized sleep therapies are enhancing treatment outcomes and patient adherence. Moreover, the growing acceptance of telemedicine and digital health platforms is facilitating remote access to sleep evaluation and treatment, thereby expanding market reach.

Market Restraints:

Despite promising growth prospects, the sleep aids market faces challenges related to regulatory approvals, safety concerns associated with long-term use of certain medications, and variable efficacy of non-pharmacological interventions. Stringent regulations governing the approval and marketing of sleep aid products impose compliance burdens on manufacturers and healthcare providers, influencing market entry strategies and operational costs. Limited reimbursement coverage for sleep disorder treatments in some regions also poses a barrier to market penetration, particularly in emerging economies.

Market Opportunities:

The sleep aids market presents significant growth opportunities driven by technological innovations in sleep diagnostics and treatment modalities. Advancements in neurostimulation devices, cognitive behavioral therapies, and novel pharmacological agents are expanding the therapeutic options available to clinicians and patients. Furthermore, the integration of artificial intelligence (AI) and big data analytics in sleep research is facilitating personalized treatment plans and predictive insights into sleep disorders. Strategic collaborations between healthcare providers, technology developers, and regulatory bodies are essential to capitalize on emerging opportunities and navigate the evolving regulatory landscape.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the sleep aids market globally?
Which types of sleep aids and therapeutic approaches are gaining traction across different demographics?
How are technological advancements reshaping the competitive landscape of the sleep aids market?
Who are the key players contributing to the sleep aids market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global sleep aids market?

Competitive Intelligence and Business Strategy:

Leading players in the global sleep aids market, including pharmaceutical companies, medical device manufacturers, and digital health innovators, focus on innovation, clinical research, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop next-generation sleep aid products, such as advanced pharmaceutical formulations, wearable sleep monitors, and AI-driven sleep management platforms. Collaborations with sleep clinics, academic institutions, and regulatory agencies facilitate product development, market access, and patient education initiatives. Moreover, emphasis on evidence-based practice and patient-centric care fosters market growth and improves treatment outcomes in the dynamic sleep aids landscape.

Key Companies Profiled:

ResMed Inc.
Koninklijke Philips N.V.
Merck & Co. Inc.
Drive DeVilbiss Healthcare LLC
GlaxoSmithKline Plc.
Fisher & Paykel Healthcare Limited
Sanofi SA
Pfizer Inc.

Key Segments Covered in Global Industry Research

Product:

Drugs
Devices

Indication:

Insomnia
Sleep Deprivation
Narcolepsy
Sleep Apnea

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
e commerce
Drug Stores

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis
4.2. Key Regulations
4.3. Disease Epidemiology
4.4. Pipeline Assessment
4.5. Recent Product launches/ Approvals
4.6. PESTEL Analysis
4.7. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Sleep Market Overview
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increase in R&D Spending
- 5.2.2. Rising Population with Sleep Disorders
- 5.2.3. Growing Lifestyle Disease Prevalence
- 5.2.4. Cost of Products
- 5.2.5. Product Features
- 5.2.6. Advancements in Technology
- 5.2.7. Changes in Regulatory Policies
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Indication
- 6.1.3. By Distribution Channel
- 6.1.4. By Country
6.2. 2024 Market Scenario

7. Global Sleep Aids Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Product

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2024-2033
- 8.3.1. Drugs
  - 8.3.1.1. Insomnia Treatment Drugs
    - 8.3.1.1.1. Doxepin Hydrochloride
    - 8.3.1.1.2. Eszopiclone
    - 8.3.1.1.3. Ramelteon
    - 8.3.1.1.4. Triazolam
    - 8.3.1.1.5. Zaleplon
    - 8.3.1.1.6. Quazepam
    - 8.3.1.1.7. Others
  - 8.3.1.2. Narcolepsy Treatment Drugs
    - 8.3.1.2.1. Modafinil
    - 8.3.1.2.2. Sodium Oxybate
    - 8.3.1.2.3. Armodafinil
    - 8.3.1.2.4. Others
- 8.3.2. Devices
  - 8.3.2.1. CPAP Devices
  - 8.3.2.2. BiPAP Devices
  - 8.3.2.3. APAP Devices
- 8.3.3. Others
  - 8.3.3.1. Mattresses and Pillows
  - 8.3.3.2. Chin Straps
  - 8.3.3.3. Mouth Pieces and Nasal Devices
8.4. Market Attractiveness Analysis By Product

9. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
- 9.3.1. Insomnia
- 9.3.2. Sleep Deprivation
- 9.3.3. Narcolepsy
- 9.3.4. Sleep Apnea
- 9.3.5. Others
9.4. Market Attractiveness Analysis By Indication

10. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2024-2033
- 10.3.1. Hospital Pharmacies
- 10.3.2. Retail Pharmacies
- 10.3.3. e commerce
- 10.3.4. Drug Stores
- 10.3.5. Others
10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033, By Region

11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. East Asia
- 11.3.5. South Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region

12. North America Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Product
- 12.3.3. By Indication
- 12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product
- 12.4.3. By Indication
- 12.4.4. By Distribution Channel
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Key Players - Intensity Mapping
12.8. Country Level Analysis & Forecast
- 12.8.1. U.S. Sleep Aids Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.1.2.1. By Product
    - 12.8.1.2.2. By Indication
    - 12.8.1.2.3. By Distribution Channel
- 12.8.2. Canada Sleep Aids Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.2.2.1. By Product
    - 12.8.2.2.2. By Indication
    - 12.8.2.2.3. By Distribution Channel

13. Latin America Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Mexico
  - 13.3.1.2. Brazil
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
- 13.3.2. By Product
- 13.3.3. By Indication
- 13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By Indication
- 13.4.4. By Distribution Channel
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Key Players - Intensity Mapping
13.8. Country Level Analysis & Forecast
- 13.8.1. Mexico Sleep Aids Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Product
    - 13.8.1.2.2. By Indication
    - 13.8.1.2.3. By Distribution Channel
- 13.8.2. Brazil Sleep Aids Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Product
    - 13.8.2.2.2. By Indication
    - 13.8.2.2.3. By Distribution Channel
- 13.8.3. Argentina Sleep Aids Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.3.2.1. By Product
    - 13.8.3.2.2. By Indication
    - 13.8.3.2.3. By Distribution Channel

14. Europe Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. Germany
  - 14.3.1.2. Italy
  - 14.3.1.3. France
  - 14.3.1.4. U.K.
  - 14.3.1.5. Spain
  - 14.3.1.6. BENELUX
  - 14.3.1.7. Russia
  - 14.3.1.8. Rest of Europe
- 14.3.2. By Product
- 14.3.3. By Indication
- 14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Indication
- 14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
- 14.8.1. Germany Sleep Aids Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Product
    - 14.8.1.2.2. By Indication
    - 14.8.1.2.3. By Distribution Channel
- 14.8.2. Italy Sleep Aids Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Product
    - 14.8.2.2.2. By Indication
    - 14.8.2.2.3. By Distribution Channel
- 14.8.3. France Sleep Aids Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Product
    - 14.8.3.2.2. By Indication
    - 14.8.3.2.3. By Distribution Channel
- 14.8.4. U.K. Sleep Aids Market Analysis
  - 14.8.4.1. Introduction
  - 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.4.2.1. By Product
    - 14.8.4.2.2. By Indication
    - 14.8.4.2.3. By Distribution Channel
- 14.8.5. Spain Sleep Aids Market Analysis
  - 14.8.5.1. Introduction
  - 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.5.2.1. By Product
    - 14.8.5.2.2. By Indication
    - 14.8.5.2.3. By Distribution Channel
- 14.8.6. BENELUX Sleep Aids Market Analysis
  - 14.8.6.1. Introduction
  - 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.6.2.1. By Product
    - 14.8.6.2.2. By Indication
    - 14.8.6.2.3. By Distribution Channel
- 14.8.7. Russia Sleep Aids Market Analysis
  - 14.8.7.1. Introduction
  - 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.7.2.1. By Product
    - 14.8.7.2.2. By Indication
    - 14.8.7.2.3. By Distribution Channel

15. East Asia Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Product
- 15.3.3. By Indication
- 15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Indication
- 15.4.4. By Distribution Channel
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
- 15.8.1. China Sleep Aids Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Product
    - 15.8.1.2.2. By Indication
    - 15.8.1.2.3. By Distribution Channel
- 15.8.2. Japan Sleep Aids Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Product
    - 15.8.2.2.2. By Indication
    - 15.8.2.2.3. By Distribution Channel
- 15.8.3. South Korea Sleep Aids Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Product
    - 15.8.3.2.2. By Indication
    - 15.8.3.2.3. By Distribution Channel

16. South Asia Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Indonesia
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Thailand
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Product
- 16.3.3. By Indication
- 16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Indication
- 16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
- 16.8.1. India Sleep Aids Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Product
    - 16.8.1.2.2. By Indication
    - 16.8.1.2.3. By Distribution Channel
- 16.8.2. Indonesia Sleep Aids Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Product
    - 16.8.2.2.2. By Indication
    - 16.8.2.2.3. By Distribution Channel
- 16.8.3. Malaysia Sleep Aids Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.3.2.1. By Product
    - 16.8.3.2.2. By Indication
    - 16.8.3.2.3. By Distribution Channel
- 16.8.4. Thailand Sleep Aids Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.4.2.1. By Product
    - 16.8.4.2.2. By Indication
    - 16.8.4.2.3. By Distribution Channel

17. Oceania Sleep Aids Market 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Product
- 17.3.3. By Indication
- 17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Indication
- 17.4.4. By Distribution Channel
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
- 17.8.1. Australia Sleep Aids Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Product
    - 17.8.1.2.2. By Indication
    - 17.8.1.2.3. By Distribution Channel
- 17.8.2. New Zealand Sleep Aids Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Product
    - 17.8.2.2.2. By Indication
    - 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Sleep Aids Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Turkey
  - 18.3.1.3. North Africa
  - 18.3.1.4. South Africa
  - 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Product
- 18.3.3. By Indication
- 18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Indication
- 18.4.4. By Distribution Channel
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Players - Intensity Mapping
18.8. Country Level Analysis & Forecast
- 18.8.1. GCC Countries Sleep Aids Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.1.2.1. By Product
    - 18.8.1.2.2. By Indication
    - 18.8.1.2.3. By Distribution Channel
- 18.8.2. Turkey Sleep Aids Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.2.2.1. By Product
    - 18.8.2.2.2. By Indication
    - 18.8.2.2.3. By Distribution Channel
- 18.8.3. South Africa Sleep Aids Market Analysis
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.3.2.1. By Product
    - 18.8.3.2.2. By Indication
    - 18.8.3.2.3. By Distribution Channel
- 18.8.4. North Africa Sleep Aids Market Analysis
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.4.2.1. By Product
    - 18.8.4.2.2. By Indication
    - 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis

20. Competition Analysis

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
- 20.3.1. ResMed Inc.
  - 20.3.1.1. Overview
  - 20.3.1.2. Product Portfolio
  - 20.3.1.3. Sales Footprint
  - 20.3.1.4. Key Financials
  - 20.3.1.5. SWOT Analysis
  - 20.3.1.6. Strategy Overview
    - 20.3.1.6.1. Marketing Strategy
    - 20.3.1.6.2. Product Strategy
    - 20.3.1.6.3. Channel Strategy
- 20.3.2. Koninklijke Philips N.V.
  - 20.3.2.1. Overview
  - 20.3.2.2. Product Portfolio
  - 20.3.2.3. Sales Footprint
  - 20.3.2.4. Key Financials
  - 20.3.2.5. SWOT Analysis
  - 20.3.2.6. Strategy Overview
    - 20.3.2.6.1. Marketing Strategy
    - 20.3.2.6.2. Product Strategy
    - 20.3.2.6.3. Channel Strategy
- 20.3.3. Merck & Co. Inc.
  - 20.3.3.1. Overview
  - 20.3.3.2. Product Portfolio
  - 20.3.3.3. Sales Footprint
  - 20.3.3.4. Key Financials
  - 20.3.3.5. SWOT Analysis
  - 20.3.3.6. Strategy Overview
    - 20.3.3.6.1. Marketing Strategy
    - 20.3.3.6.2. Product Strategy
    - 20.3.3.6.3. Channel Strategy
- 20.3.4. Drive DeVilbiss Healthcare LLC
  - 20.3.4.1. Overview
  - 20.3.4.2. Product Portfolio
  - 20.3.4.3. Sales Footprint
  - 20.3.4.4. Key Financials
  - 20.3.4.5. SWOT Analysis
  - 20.3.4.6. Strategy Overview
    - 20.3.4.6.1. Marketing Strategy
    - 20.3.4.6.2. Product Strategy
    - 20.3.4.6.3. Channel Strategy
- 20.3.5. GlaxoSmithKline Plc.
  - 20.3.5.1. Overview
  - 20.3.5.2. Product Portfolio
  - 20.3.5.3. Sales Footprint
  - 20.3.5.4. Key Financials
  - 20.3.5.5. SWOT Analysis
  - 20.3.5.6. Strategy Overview
    - 20.3.5.6.1. Marketing Strategy
    - 20.3.5.6.2. Product Strategy
    - 20.3.5.6.3. Channel Strategy
- 20.3.6. Fisher & Paykel Healthcare Limited
  - 20.3.6.1. Overview
  - 20.3.6.2. Product Portfolio
  - 20.3.6.3. Sales Footprint
  - 20.3.6.4. Key Financials
  - 20.3.6.5. SWOT Analysis
  - 20.3.6.6. Strategy Overview
    - 20.3.6.6.1. Marketing Strategy
    - 20.3.6.6.2. Product Strategy
    - 20.3.6.6.3. Channel Strategy
- 20.3.7. Sanofi SA
  - 20.3.7.1. Overview
  - 20.3.7.2. Product Portfolio
  - 20.3.7.3. Sales Footprint
  - 20.3.7.4. Key Financials
  - 20.3.7.5. SWOT Analysis
  - 20.3.7.6. Strategy Overview
    - 20.3.7.6.1. Marketing Strategy
    - 20.3.7.6.2. Product Strategy
    - 20.3.7.6.3. Channel Strategy
- 20.3.8. Pfizer Inc
  - 20.3.8.1. Overview
  - 20.3.8.2. Product Portfolio
  - 20.3.8.3. Sales Footprint
  - 20.3.8.4. Key Financials
  - 20.3.8.5. SWOT Analysis
  - 20.3.8.6. Strategy Overview
    - 20.3.8.6.1. Marketing Strategy
    - 20.3.8.6.2. Product Strategy
    - 20.3.8.6.3. Channel Strategy